1. Home
  2. IBN vs SNY Comparison

IBN vs SNY Comparison

Compare IBN & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBN
  • SNY
  • Stock Information
  • Founded
  • IBN 1955
  • SNY 1994
  • Country
  • IBN India
  • SNY France
  • Employees
  • IBN N/A
  • SNY N/A
  • Industry
  • IBN Commercial Banks
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBN Finance
  • SNY Health Care
  • Exchange
  • IBN Nasdaq
  • SNY Nasdaq
  • Market Cap
  • IBN 121.2B
  • SNY 127.2B
  • IPO Year
  • IBN 1999
  • SNY N/A
  • Fundamental
  • Price
  • IBN $34.21
  • SNY $49.37
  • Analyst Decision
  • IBN
  • SNY Buy
  • Analyst Count
  • IBN 0
  • SNY 2
  • Target Price
  • IBN N/A
  • SNY $62.50
  • AVG Volume (30 Days)
  • IBN 5.4M
  • SNY 2.4M
  • Earning Date
  • IBN 04-22-2025
  • SNY 07-24-2025
  • Dividend Yield
  • IBN 0.70%
  • SNY 4.48%
  • EPS Growth
  • IBN 14.82
  • SNY 39.56
  • EPS
  • IBN 0.83
  • SNY 5.45
  • Revenue
  • IBN $23,482,887,936.00
  • SNY $48,817,552,946.00
  • Revenue This Year
  • IBN N/A
  • SNY $3.39
  • Revenue Next Year
  • IBN $14.57
  • SNY $7.05
  • P/E Ratio
  • IBN $20.19
  • SNY $17.77
  • Revenue Growth
  • IBN 40.52
  • SNY N/A
  • 52 Week Low
  • IBN $25.13
  • SNY $45.80
  • 52 Week High
  • IBN $34.50
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • IBN 56.67
  • SNY 38.24
  • Support Level
  • IBN $33.61
  • SNY $51.80
  • Resistance Level
  • IBN $34.50
  • SNY $52.41
  • Average True Range (ATR)
  • IBN 0.32
  • SNY 0.83
  • MACD
  • IBN -0.05
  • SNY -0.06
  • Stochastic Oscillator
  • IBN 61.48
  • SNY 16.44

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: